NCT04241042Unknown不适用
Clinical Validation of the Bordeaux Maze Test
Parc de Salut Mar1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年4月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Validation of the Bordeaux Maze Test
研究概览
简要总结
Currently, the instruments used in translational studies related to cognition have proved to be inaccurate. For this reason, the objective of this study is to evaluate whether the Bordeaux Maze Test has adequate psychometric properties and is valid for its use to compare trials tested in preclinical (animal) studies and clinical population with Down syndrome. Specifically, it is intended to study the domains of memory (relational memory) and executive functions (work memory), both relevant in the cognitive functioning of the population with Down syndrome.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 16 Years 至 35 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Down syndrome population:
- •Males and females aged 16 to 35 years.
- •Clinical diagnosis of DS (full trisomy 21 or translocated) confirmed by chromosomal analysis (karyotyping).
- •Parent or legal guardian/representative and caregiver willing to give written informed consent.
- •Study participants must have sufficient vision and hearing to participate in study evaluations. Mild hearing loss will be allowed.
- •Availability of parent/caregiver to accompany the subject to clinical visits.
- •Subjects must be able to understand basic instructions.
- •Parent or legal guardian/representative and caregiver willing to give written informed consent
- •Normotypical population:
- •Males and females aged 18 to 35 years.
- •Clinical history and physical examination demonstrating no organic or psychiatric disorders.
- •Understanding and accepting the study procedures and signing the informed consent.
排除标准
- •Study participants with a current DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) diagnosis of any primary or secondary psychiatric diagnoses (such as autism spectrum disorder, attention deficit hyperactivity disorder, depression and conduct disorder). Participation are allowed as long as they are considered stable and their medication with a regime that does not change in the 6 weeks prior to enrolment and does not interfere with the progression of the study.
- •Subjects with evidence of dementia or meeting clinical diagnoses for dementia.
- •Subjects thyroid dysfunction or diabetes that is not adequately controlled or stabilized on treatment for at least 8 weeks prior to randomization.
- •Personal history of infantile spasms, of epilepsy, of severe head trauma or Central Nervous System (CNS) infections (e.g. meningitis), with the exception of a single isolated febrile seizure.
- •Subjects with past history of seizures from primary causes (such as West syndrome and Lennox-Gastaut syndrome) or secondary causes.
- •Clinical history of moderate or severe Obstructive Sleep Apnea (OSA) as defined by Apnea-Hypopnea Index (AHI) (>15 events per hour not well controlled by positive airway pressure therapy with stable settings) for at least 3 months prior to screening visit.
- •Alcohol and/or substance use disorder in the past year.
- •Concomitant disease or condition or any clinically significant finding at screening that could interfere with the conduct of the study, or that would, in the opinion of the investigator, could lead to an unacceptable risk to the subject in this study.
- •Participation in other clinical trials in the last 3 months prior to the study.
结局指标
主要结局
Validation of the Bordeaux Maze Test
时间窗: Changes from months 0 to months 1 and 3
To validate a novel neuropsychological test, the Bordeaux Maze Test for the evaluation of working memory in subjects with Down syndrome (DS)
次要结局
- Criteria validity(months 0, 1 and 3)
- Analyses of the stability: Learning and practice effects observe on the NIH Toolbox(months 0, 1 and 3)
- Test retest reliability(months 0, 1 and 3)
- Analyses of the stability: Learning and practice effects observe on the Bordeaux Maze Test(months 0, 1 and 3)
- Analyses of the stability: Floor/ ceiling effects on the Bordeaux Maze Test(months 0, 1 and 3)
- Analyses of the stability: Floor/ ceiling effects on the NIH Toolbox(months 0, 1 and 3)
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Validation of Cognitive Screenings for the Hearing ImpairedDementiaAuditory Processing DisorderHearing LossNCT03648502University College, London78
已完成
不适用
Validation of tests for cognitive function, and the effect of Yokukansankachimpihange on cognitive and non-cognitive symptomsdementiaJPRN-UMIN000009232Polyene Project, Inc.30
招募中
Unknown
The effectiveness of transdiagnostic cognitive behavioral therapy in people with generalized anxiety symptomsGeneralized anxiety disorder.Generalized anxiety disorderF41.1IRCT20240709062376N1Hakim Toos Institute of Higher Education30
已完成
不适用
Translational Research Evaluating Neurocognitive Memory ProcessesNeurocognitionNCT01834677Duke University76
招募中
不适用
Development of tablet-based neurocognitive tests for patients with schizophreniaschizophreniaJPRN-UMIN000048695Hokkaido university100